Malaria vaccine, which injects live parasites into patients shows remarkable success
Twelve out of 15 test subjects react positively to the vaccine
A new malaria vaccine which is being developed in the U.S. has protected 12 out of 15 patients from the disease. When administered in high doses, the vaccine has shown promising results in early stage clinical trials. The vaccine's method is highly unique as it involves injecting live but weakened malaria-causing parasites directly into patients to trigger immunity.
It's a longstanding notion that exposure to mosquitoes treated with radiation can protect against malaria. Studies have proven, however that it takes more than 1,000 bites from the insects over time to build up a high level of immunity, making it an impractical method of widespread protection.
A U.S. biotech company called Sanaria has taken lab-grown mosquitoes, irradiated them and then extracted the malaria-causing parasite (Plasmodium falciparum), all under sterile conditions. The still-living if weakened parasites are then counted and placed in vials, where they can then be injected directly into a patient's bloodstream.
This vaccine candidate is called PfSPZ. Researchers then looked at a group of 57 volunteers for the trial vaccine, none of whom had had malaria before.
Forty of the 57 received different doses of the vaccine, while 17 did not. The test subject were then all exposed to the malaria-carrying mosquitoes. Researchers then discovered that for the participants not given vaccine, coupled with those given low doses, almost all became infected with malaria.
For the small group given the highest dosage, only three of the 15 patients became infected after exposure to malaria.
"Based on the history, we knew dose was important because you needed 1,000 mosquito bites to get protection - this validates that," Seder says.
"It allows us in future studies to increase the dose and alter the schedule of the vaccine to further optimize it. The next critical questions will be whether the vaccine is durable over a long period of time and can the vaccine protect against other strains of malaria."
The fact that the vaccine had to be injected into the bloodstream rather than into or under the skin made delivery more difficult.
"They are clearly very early stage trials in small numbers of volunteers, but without question we are extremely encouraged by the results," Dr. Ashley Birkett, from the Path Malaria Vaccine Initiative, said.
According to the latest figures from the World Health Organization, there were an estimated 219 million cases of malaria in 2010 and an estimated 660,000 deaths.
Malaria kills about 600,000 people annually and infects more than 200 million.
© 2013, Distributed by NEWS CONSORTIUM.
Pope Francis Prayer Intentions for December 2013
General Intention: Victimized Children. That children who are victims of abandonment or violence may find the love and protection they need.
Missionary Intention: Prepare the Savior's Coming. That Christians, enlightened by the Word incarnate, may prepare humanity for the Savior's coming.
Rate This Article
Leave a Comment
More Health News
- FDA gives guidelines to limit use of antibiotics in livestock
- Exercise reduces chances of dementia, lengthy study concludes
- Obamacare crashing in model states like California as 70 percent of doctors opt out
- New hepatitis-C drug approved by FDA
- Donors from around the world say that an AIDS-free generation may be within sight
- Washington signing up more people for Medicaid than private plans
- Man documents ravages of diabetes to his feet as they decay within 10 DAYS
- Dementia epidemic only growing worse: 135 million sufferers could arrive by 2050
- Men are from Mars, Women from Venus? Their brains are certainly wired differently
- Fr. Paul Schenck: Finding Living Faith on Catechetical Sunday
- The Movie Yellow: Incest as 'Normal' and Cassavates's Slides Into the World of Woes
- The Chicago School Teachers Strike Reveals the Need For School Choice
- The Sexual Barbarians and the Dissolution of Culture
- The Happy Priest Challenges Us to Ask: Who is Jesus to Me?
- Michael Coren on Canadian Public Schools: Teachers, leave those kids alone
- We Cannot Ignore Our Consciences: Cardinal Dolan On Religious Liberty
- In the Face of Danger, Successor of Peter Travels to Lebanon as a Messenger of Peace
- Reflections on the Dignity and Vocation of Women: Who or What?